Galloway Reports Change in Accendra Health Ownership

TL;DR

**Insider Heath H. Galloway reported a change in ownership of Accendra Health shares.**

AI Summary

This Form 4 filing, dated March 24, 2026, reports that Heath H. Galloway, an insider at Accendra Health Inc./VA/, engaged in a transaction on March 20, 2026. While the specific details of the transaction (buy/sell, number of shares, dollar amount) are not provided in this excerpt, the filing indicates a change in beneficial ownership. This matters to investors because insider transactions can signal management's confidence (or lack thereof) in the company's future prospects, potentially influencing stock price movements.

Why It Matters

Insider transactions like this can provide clues about how company executives view the stock's value, which can be a significant factor for current and potential shareholders.

Risk Assessment

Risk Level: low — This filing is purely informational and does not inherently pose a direct financial risk, though the underlying transaction might.

Analyst Insight

A smart investor would look for the full Form 4 document to understand the specific nature of the transaction (buy or sell, quantity, price) to gauge the insider's sentiment towards Accendra Health Inc./VA/ and then cross-reference with other company news or financial performance.

Key Players & Entities

• Galloway Heath H (person) — Reporting insider
• ACCENDRA HEALTH INC/VA/ (company) — Issuer of securities
• March 24, 2026 (date) — Filing Date
• March 20, 2026 (date) — Period of Report

FAQ

Filing Documents

• form4.html (4)
• form4.xml (4) — 3KB
• 0000075252-26-000013.txt ( ) — 5KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Galloway Heath H (Last) (First) (Middle) ACCENDRA HEALTH INC. 4435 WATERFRONT DRIVE (Street) GLEN ALLEN VIRGINIA 23060 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol ACCENDRA HEALTH INC/VA/ [ ACH ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP,General Counsel & CorpSecy 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/20/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/20/2026 F 9,347 (1) D $ 2.03 169,094 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Heath H. Galloway by Rosemarie France, POA 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR